|
|
|
Insider
Information: |
Colella Samuel D |
Relationship: |
Director |
City: |
Santa Clara |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
203,276 |
|
Indirect Shares
|
2,453,199 |
|
|
Direct
Value |
$750,599 |
|
|
Indirect Value
|
$21,111,466 |
|
|
Total
Shares |
2,656,475 |
|
|
Total
Value |
$21,862,065 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
130.6%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Genomic Health Inc |
GHDX |
Director |
2014-10-01 |
5,305 |
2014-10-01 |
54,348 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2010-01-26 |
36,862 |
2010-01-26 |
2,183,128 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2006-05-15 |
13,713 |
Premium* |
|
Insulet Corp |
PODD |
Former 10% Owner |
2007-05-14 |
0 |
2007-05-14 |
89,372 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2007-06-06 |
0 |
2008-07-21 |
13,247 |
Premium* |
|
Fluidigm Corp |
FLDM |
Director |
2020-03-11 |
161,109 |
2020-03-11 |
78,159 |
Premium* |
|
Veracyte, Inc. |
VCYT |
Director, 10% Owner |
2013-11-04 |
0 |
2013-11-04 |
21,232 |
Premium* |
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2021-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FLDM |
Fluidigm Corp |
Director |
|
2013-11-04 |
4/A |
A |
$0.00 |
$0 |
D/D |
8,796 |
19,673 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-01-01 |
4 |
A |
$29.27 |
$9,981 |
D/D |
341 |
4,221 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
105,780 |
|
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,793,335 |
2,899,115 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2014-02-18 |
4 |
B |
$13.00 |
$3,999,996 |
I/I |
307,692 |
3,206,807 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-04-01 |
4 |
A |
$26.57 |
$9,990 |
D/D |
376 |
4,597 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-07-01 |
4 |
A |
$27.86 |
$9,974 |
D/D |
358 |
4,955 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2014-10-01 |
4 |
A |
$28.54 |
$9,989 |
D/D |
350 |
5,305 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-18 |
4 |
S |
$38.71 |
$340,659 |
D/D |
(8,800) |
19,673 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-18 |
4 |
OE |
$16.00 |
$140,800 |
D/D |
8,800 |
28,473 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-19 |
4 |
S |
$38.97 |
$1,513,727 |
D/D |
(38,840) |
19,673 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-19 |
4 |
OE |
$4.45 |
$461,961 |
D/D |
38,840 |
58,513 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-20 |
4 |
S |
$38.92 |
$221,849 |
D/D |
(5,700) |
19,673 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2015-02-20 |
4 |
OE |
$4.45 |
$25,343 |
D/D |
5,700 |
25,373 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2016-03-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
550 |
19,123 |
0 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2016-06-08 |
4 |
B |
$14.00 |
$9,999,990 |
I/I |
714,285 |
20,739 |
2.25 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2016-06-20 |
4 |
B |
$13.70 |
$93,833 |
D/D |
6,778 |
6,778 |
3.92 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2016-06-21 |
4 |
B |
$13.62 |
$255,766 |
D/D |
18,726 |
25,504 |
3.92 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2016-11-21 |
4 |
B |
$18.00 |
$599,994 |
I/I |
33,333 |
33,333 |
2.25 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2016-11-30 |
4 |
B |
$6.32 |
$126,470 |
D/D |
20,000 |
39,123 |
2.39 |
- |
|
FLXN |
Flexion Therapeutics Inc |
Director |
|
2016-12-01 |
4 |
B |
$16.38 |
$163,807 |
I/I |
10,000 |
43,333 |
2.25 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2016-12-14 |
4 |
B |
$7.39 |
$36,935 |
D/D |
5,000 |
44,123 |
2.39 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2016-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
600 |
43,523 |
0 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-03-14 |
4 |
B |
$5.00 |
$49,973 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
FLDM |
Fluidigm Corp |
Director |
|
2017-05-09 |
4 |
B |
$5.93 |
$44,438 |
I/I |
7,500 |
17,500 |
2.1 |
- |
|
105 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|